MED logo

MEDMedifast Inc

$11.98
$0.03
(0.25%)
Today
Closed $12.07
$0.09
(0.75%)
After Hours
Updated: 05:49 PM EDT
EarningsAug 10
Mkt Cap$134.54M
Vol147,107.00
37

Bearish Sentiment

How do you feel about MED?

News
all
press releases
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound?
Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
More News
News Placeholder
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year?
Here is how Medifast (MED) and New York Times Co. (NYT) have performed compared to their sector so far this year.
Zacks
News Placeholder
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer
Medifast, Inc. (NYSE: MED) today announced that its Board of Directors has formally appointed Nicholas Johnson as Chief Executive Officer, effective June 1, 2026. Johnson will succeed Dan Chard as CEO, who will continue to serve as Chairman of the Board. The appointment follows the leadership...
Business Wire
News Placeholder
3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNY
These highly ranked medical stocks have been capitalizing on their sales expansion, and their defensive or secular growth profiles could become even more attractive if an economic downturn emerges.
Zacks
News Placeholder
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
MED beats first-quarter estimates despite steep revenue declines, while stronger coach productivity and a new product launch support recovery hopes.
Zacks
News Placeholder
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care
HIMS broadens its DTC platform with GLP-1 access, a new Benefits hub and global expansion to broaden convenient, personalized care.
Zacks
News Placeholder
Medifast Q1 Earnings Call Highlights
Medifast (NYSE:MED) reported first-quarter 2026 results that management characterized as an early step toward stabilizing the business as it pivots from traditional weight loss to a broader metabolic...
MarketBeat
News Placeholder
Medifast (MED) Reports Q1 Loss, Tops Revenue Estimates
Medifast (MED) delivered earnings and revenue surprises of +65.46% and +3.11%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Medifast (NYSE:MED) Releases FY 2026 Earnings Guidance
Medifast (NYSE:MED) updated its FY 2026 earnings guidance. The company provided EPS guidance of -2.750--1.550 for the period, compared to the consensus estimate of -1.980. The company also issued...
MarketBeat
News Placeholder
Medifast (NYSE:MED) Issues Q2 2026 Earnings Guidance
Medifast (NYSE:MED) updated its second quarter 2026 earnings guidance. The company provided EPS guidance of -1.000--0.500 for the period, compared to the consensus estimate of -0.430. The company...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.